Kenneth Anderson, MD

Dana-Farber Cancer InstituteBoston, Massachusetts - 02115 Dana-Farber Cancer Institute/Brigham & Women's ...Boston, Massachusetts - 02115 |
- CLINICAL TRIALS 2
- CONDITIONS2
- INTERVENTIONS4
- SINCE2005

Bortezomib Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma
August 2006 - August 2010

Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma
April 2005 - September 2011
Multiple Myeloma
Neoplasms, Plasma Cell
Lenalidomide
Bortezomib
Dexamethasone
Dendritic Cell Tumor Fusion



